[Asia Economy Reporter Ji Yeon-jin]
▲Hanp, subject to a substantive review of listing eligibility due to audit opinion refusal
▲Celltrion Healthcare, related to the recommendation for dismissal of an executive due to violation of accounting standards by the Securities and Futures Commission, the subject has resigned
▲Celltrion Pharm, measures including fines, audit designation, internal control improvement recommendations, and corrective demands
▲PNT, signed a supply contract for secondary battery electrode process equipment worth 56.9 billion KRW
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
▲SD Life Science, operating profit decreased by 838%, recording an operating loss of 34.8 billion KRW
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
